Javascript must be enabled to continue!
ANTIBODIES IN THE PIG AGAINST PIG INSULIN
View through CrossRef
ABSTRACT
Sera from three pigs injected subcutaneously with respectively pig, ox, and horse insulin for 87 days were incubated with 131I-pig insulin and investigated for the presence of antibodies by means of immunoelectrophoresis and autoradiography.
A binding of 131I-pig insulin to the gamma globulin fraction could be demonstrated in all animals after the commencement of the injections. Thus a cross reactivity between pig and ox insulin and pig and horse insulin occurred, however, apparently to a lesser degree in the latter case. The presence of a 131I-pig insulin binding gamma fraction in the serum from the animal injected with pig insulin, indicates a formation of antibodies against pig insulin in the pig.
Title: ANTIBODIES IN THE PIG AGAINST PIG INSULIN
Description:
ABSTRACT
Sera from three pigs injected subcutaneously with respectively pig, ox, and horse insulin for 87 days were incubated with 131I-pig insulin and investigated for the presence of antibodies by means of immunoelectrophoresis and autoradiography.
A binding of 131I-pig insulin to the gamma globulin fraction could be demonstrated in all animals after the commencement of the injections.
Thus a cross reactivity between pig and ox insulin and pig and horse insulin occurred, however, apparently to a lesser degree in the latter case.
The presence of a 131I-pig insulin binding gamma fraction in the serum from the animal injected with pig insulin, indicates a formation of antibodies against pig insulin in the pig.
Related Results
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
Abstract
Abstract 4908
Insulin resistance can be a major problem in patients with diabetes mellitus. Although multiple reasons can result in this prob...
THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT, INSULIN ANALOG, AND HUMAN INSULIN OF CHILDREN WITH DIABETES
THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT, INSULIN ANALOG, AND HUMAN INSULIN OF CHILDREN WITH DIABETES
The aim of this study is to evaluate the cost-effectiveness of continuous subcutaneous insulin infusion (CSII) to multiple daily insulin injection (MDI) either with analogues or w...
WILLINGNESS-TO-PAY FOR INSULIN IN DIABETES TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
WILLINGNESS-TO-PAY FOR INSULIN IN DIABETES TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
Background: Insulin treatment is necessary for all patients with type 1 diabetes and a subset of patients with type 2 diabetes. However, lifetime insulin treatment is relatively co...
Detection of Insulin in Insulin-Deficient Islets of Patients with Type 1 Diabetes
Detection of Insulin in Insulin-Deficient Islets of Patients with Type 1 Diabetes
Type 1 diabetes (T1D) is related to the autoimmune destruction of β-cells, leading to their almost complete absence in patients with longstanding T1D. However, endogenous insulin s...
Immunoassay of serum polypeptide hormones by using 125I-labelled anti(-immunoglobulin G) antibodies
Immunoassay of serum polypeptide hormones by using 125I-labelled anti(-immunoglobulin G) antibodies
1. A technique for indirectly labelling antibodies to polypeptide hormones, by combining them with radioactively labelled anti-(immunoglobulin G) is described. (a) 125I-labelled an...
KELCH-3 (KLHL3): A Potential Regulator of Insulin-Induced Renal
Haemodynamic Alterations in Obesity
KELCH-3 (KLHL3): A Potential Regulator of Insulin-Induced Renal
Haemodynamic Alterations in Obesity
Background: The contribution of elevated insulin levels to renal
disease in pre-diabetic obesity remains underappreciated, as glomerular
...
940-P: Porous Insulin Microneedles for Diabetes Treatment
940-P: Porous Insulin Microneedles for Diabetes Treatment
Introduction and Objective: Patients with type 1 and type 2 diabetes are subjected to insulin injection therapies. Repeated subcutaneous insulin administrations leads to physiologi...

